Breaking News

Sartorius Expands Cell Culture Media Capabilities

Pays $45 million for a majority stake in cell culture media specialist Biological Industries.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sartorius has signed an agreement to acquire a majority stake in the Israeli cell culture media developer and manufacturer Biological Industries. For approximately €45 million, Sartorius is acquiring just over 50% of the company from its owners, Kibbutz Beit Haemek and private equity fund Fortissimo Capital. An option to acquire a further 20% of the shares within three years was also agreed. The transaction is subject to customary closing conditions and expected to be finalized by mid-December. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters